Project Details
Description
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of MRM-3379 in Male Participants with Fragile X Syndrome
| Status | Active |
|---|---|
| Effective start/end date | 12/1/25 → 12/16/36 |
Funding
- MIRUM PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.